Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Ballard Power Systems, Herbalife, and Intercept Pharmaceuticals Tumbled Today

By Dan Caplinger - Mar 17, 2014 at 8:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A lack of any negative surprises from the Crimean region sent stock markets soaring, but these three stocks didn't join in the rally Monday. Find out what sent these stocks slumping today.

On Monday, investors were generally pleased after the weekend's events between Ukraine and Russia turned out not to be as bad as some had feared last Friday. Yet even though the Dow, S&P 500, and other major stock market measures rose about 1% today, investors in Ballard Power Systems ( BLDP -5.57% ), Herbalife ( HLF -0.27% ), and Intercept Pharmaceuticals ( ICPT -8.28% ) weren't so lucky, suffering substantial losses today.

Ballard Power Systems dropped 9% on a bad day for fuel-cell stocks generally, as peers Plug Power ( PLUG -8.13% ) and FuelCell Energy ( FCEL -10.55% ) declined 3% and 7% respectively. Skeptics have started raising the question of whether fuel-cell stocks truly have the growth potential that their recent share-price performance suggests, and one problem that Ballard and its industry counterparts face is that even though their technology is in the spotlight right now, trends among alternative energy producers tend to run hot and cold over time, suggesting that now could be a bad time to get into the space. For Ballard, one institutional investor might well have come to that conclusion, as major investor Anglo American Platinum converted a promissory note into shares last Friday. The move will make it easier for Anglo American to sell its stake in the fuel-cell company, adding one more investor to the list of those who think that the sector has come too far too fast.

Herbalife declined 8%, adding to its 10% drop last week. The controversy over an investigation into the multi-level marketing company's business practices turned political Monday, as the Republican opponent of the Massachusetts Senate member who called for regulators to investigate Herbalife filed an ethics complaint. The allegations point to donations from Bill Ackman's Pershing Square hedge fund to political action committees that support Senate campaigns, and with Ackman having publicly taken a short position in the stock, he benefited from the downward move after the announcement of the investigation. What's increasingly clear, though, is that the investigation likely won't go away anytime soon, and so Herbalife will have potential trouble hanging over its head for the foreseeable future.

Intercept Pharmaceuticals plunged $55 per share, or 12%, today despite the biotech reporting narrower losses than year-ago levels. The company released some fairly encouraging study results that indicated that its obeticholic acid drug led to reduced levels of adverse serum alkaline phosphatase, giving Intercept more ammunition for filing for FDA approval of the drug for use against a liver disease called primary biliary cirrhosis. But with other results pointing to possible cardiovascular side effects for patients suffering from another liver disease, nonalcoholic steatohepatitis, investors are clearly nervous that the FDA might not approve the drug or at least require further trials to demonstrate the drug's safety.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Herbalife Ltd. Stock Quote
Herbalife Ltd.
$37.52 (-0.27%) $0.10
FuelCell Energy, Inc. Stock Quote
FuelCell Energy, Inc.
$7.29 (-10.55%) $0.86
Plug Power Inc. Stock Quote
Plug Power Inc.
$33.46 (-8.13%) $-2.96
Intercept Pharmaceuticals Stock Quote
Intercept Pharmaceuticals
$15.63 (-8.28%) $-1.41
Ballard Power Systems Inc. Stock Quote
Ballard Power Systems Inc.
$13.23 (-5.57%) $0.78

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.